T-cell screening tube can reliably screen neoplastic T-cell populations in AITL patients with typical immunophenotyping, such as a loss of surface CD3 and a loss of CD7 at a relatively high ratio. Here, CD7 is linked to angioimmunoblastic T-cell lymphoma.